Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Mar 25, 2011

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – MDxHealth has appointed four members to form its scientific advisory board, including Jonathan Epstein, James Herman, Gerrit Meijer, and Eric Wallen.

Epstein currently is the Reinhard professor of urologic pathology at the Johns Hopkins University School of Medicine. Herman is a professor of oncology and cancer biology at the Oncology Center at Johns Hopkins Medical Institutions, and he is a clinician at the Johns Hopkins Cancer Center. Meijer is a professor of pathology at the Free University Medical Center in Amsterdam, where he also is co-chair of the Genomics Center. Wallen is an associate professor of surgery in the division of urology at the University of North Carolina Medical Center at Chapel Hill, and he formerly was an assistant professor of urology at Dartmouth Medical School.

DNA Diagnostics Center (DDC) has hired Richard Chmelo to join its research and development efforts in developing new DNA tests. Chmelo has more than 25 years experience in developing and implementing genetic testing technologies, including experience validating and launching SNP-based genetic panels, DDC said.

Abcodia has appointed Andy Richards to be chairman of the new molecular diagnostic development company. Richards has worked at Cambridge Biotechnology, Chiroscience, Arakis, and Vectura, and he is a non-executive director at Babraham Bioscience Technology and Cancer Research Technology, among other entities.

The American College of Medical Genetics has named the late Charles Epstein winner of its ACMG Foundation Lifetime Achievement Award. Epstein, who died in February, was a researcher who focused on genetic disorders such as Down syndrome and was known for gaining recognition for medical genetics by the American Board of Medical Specialists, which led to the founding of the ACMG.

The Allen Institute for Brain Science has tapped Christof Koch to serve as its chief scientific officer. Koch arrives at the Seattle-based Allen Institute after spending 25 years working at the California Institute of Technology, where he studied the biophysical mechanisms underlying neural computation, visual attention, and the neural basis of consciousness and the subjective mind and collaborated with Francis Crick. Koch will maintain a part-time appointment and a lab at Caltech.

Stephen Warren will receive the March of Dimes/Colonel Harland Sanders Award for Lifetime Achievement in the field of genetic sciences. Warren was the first to identify the genetic abnormality that causes fragile X syndrome, the leading cause of inherited intellectual disability. Warren is the William Patterson Timmie professor of human genetics and Charles Howard Candler chair of the department of human genetics, as well as professor of biochemistry and pediatrics, at Emory University School of Medicine.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.